肝臓ジャーナル: 病気と移植

Non-Invasive Test for Estimation of Liver Fibrosis

Khishgee D, Badamsuren D and Bira N*

In 2015 the digestive disorders were the second leading cause of morbidity among Mongolian population. The observed mortality from cancer in 2013 was 23.4% including liver cancer which is the first most common cause of cancer death. Furthermore, the digestive disease related death accounts for 4.7% of all mortality. Recently many noninvasive markers for assessing liver fibrosis have been developed, and they are frequently used in clinical practice. FIB4 index had a predictive value to confirm the existence of significant fibrosis with a specificity of 74% and a sensitivity of 70% and APRI score had a sensitivity of 89% and a specificity of 75%.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません